Anemia of Chronic Kidney Disease: Which Therapeutics Are Available?

Authors

  • Sara Condeço Unidade de Saúde Familiar Novo Mirante. Agrupamento de Centros de Saúde de Loures-Odivelas. Lisboa.
  • Bernardo Marques da Silva Serviço de Nefrologia e Transplantação Renal. Centro Hospitalar Universitário Lisboa Norte. Lisboa. https://orcid.org/0000-0003-0665-4446

DOI:

https://doi.org/10.20344/amp.19381

Keywords:

Anemia/drug therapy, Renal Insufficiency, Chronic

Abstract

N/a.

Downloads

Download data is not yet available.

References

Farinha A, Robalo Nunes A, Mairos J, Fonseca C. Anemia da doença renal crónica: o estado da arte. Acta Med Port. 2022;35:758–64. DOI: https://doi.org/10.20344/amp.17284

European Medicines Agency. Roxadustat. 2022. [consultado 2022 nov 18]. Disponível em:https://www.ema.europa.eu/en/documents/product-information/evrenzo-epar-product-information_en.pdf.

Locatelli F, Minutolo R, de Nicola L, del Vecchio L. Evolving strategies in the treatment of anaemia in chronic kidney disease: the HIF-prolyl hydroxylase inhibitors. Drugs. 2022;82:1565–89. DOI: https://doi.org/10.1007/s40265-022-01783-3

McCallum W, Weiner DE. HIF-PHIs for anemia management in CKD. Clin J Am Soc Nephrol. 2022;17:1255–8. DOI: https://doi.org/10.2215/CJN.02440222

Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, et al. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) conference. Kidney Int. 2021;99:1280–95. DOI: https://doi.org/10.1016/j.kint.2021.03.020

Published

2023-03-14

How to Cite

1.
Condeço S, Marques da Silva B. Anemia of Chronic Kidney Disease: Which Therapeutics Are Available?. Acta Med Port [Internet]. 2023 Mar. 14 [cited 2024 Apr. 22];36(4):299-. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19381

Issue

Section

Letters to the Editor